Bogart Wealth LLC’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $118K | Buy |
2,247
+739
| +49% | +$39.1K | ﹤0.01% | 361 |
|
|
2026
Q1 | $83.2K | Buy |
1,508
+200
| +15% | +$10.8K | ﹤0.01% | 381 |
|
|
2025
Q4 | $64.1K | Hold |
1,308
| – | – | ﹤0.01% | 417 |
|
|
2025
Q3 | $56.5K | Buy |
1,308
+6
| +0.5% | +$234 | ﹤0.01% | 431 |
|
|
2025
Q2 | $50K | Sell |
1,302
-112
| -8% | -$4.28K | ﹤0.01% | 450 |
|
|
2025
Q1 | $54.8K | Buy |
1,414
+80
| +6% | +$2.93K | ﹤0.01% | 404 |
|
|
2024
Q4 | $45.1K | Buy |
1,334
+1
| +0.1% | +$36 | ﹤0.01% | 426 |
|
|
2024
Q3 | $54.5K | Buy |
1,333
+662
| +99% | +$27.1K | ﹤0.01% | 398 |
|
|
2024
Q2 | $25.8K | Hold |
671
| – | – | ﹤0.01% | 500 |
|
|
2024
Q1 | $28.8K | Hold |
671
| – | – | ﹤0.01% | 458 |
|
|
2023
Q4 | $24.9K | Hold |
671
| – | – | ﹤0.01% | 470 |
|
|
2023
Q3 | $24.3K | Buy |
671
+481
| +253% | +$17.1K | ﹤0.01% | 448 |
|
|
2023
Q2 | $6.77K | Sell |
190
-51
| -21% | -$1.83K | ﹤0.01% | 648 |
|
|
2023
Q1 | $8.57K | Buy |
241
+222
| +1,168% | +$7.77K | ﹤0.01% | 624 |
|
|
2022
Q4 | $668 | Sell |
19
-400
| -95% | -$13.3K | ﹤0.01% | 892 |
|
|
2022
Q3 | $12K | Hold |
419
| – | – | ﹤0.01% | 510 |
|
|
2022
Q2 | $23K | Buy |
419
+400
| +2,105% | +$22.1K | ﹤0.01% | 396 |
|
|
2022
Q1 | $1K | Sell |
19
-1,587
| -99% | -$86.2K | ﹤0.01% | 735 |
|
|
2021
Q4 | $89K | Hold |
1,606
| – | – | 0.01% | 211 |
|
|
2021
Q3 | $77K | Hold |
1,606
| – | – | 0.01% | 212 |
|
|
2021
Q2 | $80K | Hold |
1,606
| – | – | 0.01% | 206 |
|
|
2021
Q1 | $72K | Hold |
1,606
| – | – | 0.01% | 201 |
|
|
2020
Q4 | $73K | Hold |
1,606
| – | – | 0.01% | 177 |
|
|
2020
Q3 | $75K | Hold |
1,606
| – | – | 0.02% | 165 |
|
|
2020
Q2 | $82K | Hold |
1,606
| – | – | 0.02% | 149 |
|
|
2020
Q1 | $76K | Sell |
1,606
-960
| -37% | -$51.2K | 0.02% | 150 |
|
|
2019
Q4 | $151K | Hold |
2,566
| – | – | 0.05% | 118 |
|
|
2019
Q3 | $137K | Sell |
2,566
-116
| -4% | -$5.97K | 0.07% | 108 |
|
|
2019
Q2 | $134K | Sell |
2,682
-141
| -5% | -$7.08K | 0.08% | 107 |
|
|
2019
Q1 | $147K | Sell |
2,823
-542
| -16% | -$27.1K | 0.07% | 98 |
|
|
2018
Q4 | $160K | Sell |
3,365
-37,032
| -92% | -$1.82M | 0.08% | 77 |
|
|
2018
Q3 | $2.03M | Buy |
40,397
+2,631
| +7% | +$134K | 1.17% | 18 |
|
|
2018
Q2 | $1.9M | Buy |
37,766
+1,340
| +4% | +$67.5K | 1.16% | 13 |
|
|
2018
Q1 | $1.81M | Buy |
36,426
+4,030
| +12% | +$188K | 1.05% | 15 |
|
|
2017
Q4 | $1.44M | Buy |
32,396
+3,448
| +12% | +$159K | 0.92% | 28 |
|
|
2017
Q3 | $1.47M | Buy |
28,948
+295
| +1% | +$15K | 1.09% | 25 |
|
|
2017
Q2 | $1.54M | Buy |
28,653
+8,271
| +41% | +$441K | 0.99% | 20 |
|
|
2017
Q1 | $1.07M | Buy |
20,382
+335
| +2% | +$17K | 0.71% | 23 |
|
|
2016
Q4 | $965K | Buy |
+20,047
| New | +$990K | 0.65% | 29 |
|
Other funds holding GSK
JEST
Bogart Wealth LLC's GSK Position: Q2 2026 in Review
Bogart Wealth LLC increased its GSK (GSK) stake by 49% in Q2 2026, buying an estimated $39.1K and bringing the position to 2,247 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #361.
Bogart Wealth LLC first reported a position in GSK in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.03M in Q3 2018. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Bogart Wealth LLC held 2,247 shares of GSK worth $118K as of Q2 2026.
- Bogart Wealth LLC bought 739 GSK shares in Q2 2026, an estimated $39.1K.
- GSK made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #361 holding.
- Bogart Wealth LLC first reported a position in GSK in Q4 2016 and has held it in 39 quarters since.
- Bogart Wealth LLC's GSK position peaked at $2.03M in Q3 2018.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.